| 000 | 01741 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517203432.0 | ||
| 264 | 0 | _c20180730 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a0304-419X | ||
| 024 | 7 |
_a10.1016/j.bbcan.2018.02.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBirnbaum, David J | |
| 245 | 0 | 0 |
_aMolecular classification as prognostic factor and guide for treatment decision of pancreatic cancer. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta. Reviews on cancer _cApr 2018 |
||
| 300 |
_a248-255 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCarcinoma, Pancreatic Ductal _xclassification |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Heterogeneity |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Diagnostic Techniques |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xclassification |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aTranscriptome |
| 700 | 1 | _aBertucci, François | |
| 700 | 1 | _aFinetti, Pascal | |
| 700 | 1 | _aBirnbaum, Daniel | |
| 700 | 1 | _aMamessier, Emilie | |
| 773 | 0 |
_tBiochimica et biophysica acta. Reviews on cancer _gvol. 1869 _gno. 2 _gp. 248-255 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbcan.2018.02.001 _zAvailable from publisher's website |
| 999 |
_c28140136 _d28140136 |
||